Koyfin Home > Directory > Health Care > Amicus Therapeutics > Cash and Short-Term Investments

Amicus Therapeutics Cash and Short-Term Investments Chart (FOLD)

Amicus Therapeutics annual/quarterly Cash and Short-Term Investments from 2006 to 2018.
  • Amicus Therapeutics Cash and Short-Term Investments for the quarter ending December 12, 2018 was $504m a -11.58% decrease of -58m year over year
  • Amicus Therapeutics Cash and Short-Term Investments for the last 12 months ending December 12, 2018 was $504m a -11.58% decrease of -58m year over year
  • Amicus Therapeutics Annual Cash and Short-Term Investments for 2018 was $504m a 28.88% increase of 146m from 2017
  • Amicus Therapeutics Annual Cash and Short-Term Investments for 2017 was $359m a 7.87% increase of 28m from 2016
  • Amicus Therapeutics Annual Cash and Short-Term Investments for 2016 was $330m a 35.21% increase of 116m from 2015
Other Balance Sheet Metrics:
  • Amicus Therapeutics Total Assets for the quarter ending September 09, 2018 was $839m a 25.23% increase of 212m year over year
  • Amicus Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $39m a -4.44% decrease of -2m year over year
  • Amicus Therapeutics Total Equity for the quarter ending September 09, 2018 was $411m a 14.14% increase of 58m year over year
View Chart On Koyfin

Quarterly FOLD Cash and Short-Term Investments Data

12/2018$504m
09/2018$564m
06/2018$539m
03/2018$563m
12/2017$359m
09/2017$412m
06/2017$227m
03/2017$280m
12/2016$330m
09/2016$212m

Annual FOLD Cash and Short-Term Investments Data

2018$504m
2017$359m
2016$330m
2015$214m
2014$152m
2013$82m
2012$99m
2011$56m
2010$107m
2009$78m